Skip to main
NAUT
NAUT logo

Nautilus Biotechnology (NAUT) Market Capitalization Overview

Market Cap: $112.30M as of Oct 13, 2025

$112.30M
Past Month+$21.27M (23.37%)
As of Oct 13, 2025, Nautilus Biotechnology (NAUT) has a market capitalization of $112.30M. Over the past 30 days, its market cap has increased by 24.17%, while in the last 12 months, it has decreased by -46.77%.

Market capitalization represents the total value of Nautilus Biotechnology as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Nautilus Biotechnology (NAUT) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Nautilus Biotechnology (NAUT) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Nautilus Biotechnology (NAUT) Market Cap History

DateMarket CapChange
Oct 1, 2025$105.49M+24.17%
Sep 2, 2025$84.96M-11.89%
Aug 1, 2025$96.42M+4.70%
Jul 1, 2025$92.09M-0.25%
Jun 2, 2025$92.32M+6.85%
May 1, 2025$86.40M-17.49%
Apr 1, 2025$104.72M-33.06%
Mar 3, 2025$156.43M-27.15%
Feb 3, 2025$214.72M+1.18%
Jan 2, 2025$212.21M-25.55%

Nautilus Biotechnology (NAUT) End of Year Market Cap History

DateMarket CapChange
2025$112.30M-46.77%
2024$210.95M-43.53%
2023$373.59M+66.41%
2022$224.51M-65.10%
2021$643.19M

FAQs About Nautilus Biotechnology (NAUT) Market Cap

As of Oct 13, 2025, the market capitalization of Nautilus Biotechnology (NAUT) is $112.30M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Nautilus Biotechnology’s market capitalization has increased by 23.37%, changing from $91.03M to $112.30M as of Oct 13, 2025.

In the last 3 months, Nautilus Biotechnology’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Nautilus Biotechnology’s market capitalization decreased from $373.59M in January to $210.95M in December, reflecting a -43.53% change.

In the past five years, Nautilus Biotechnology (NAUT) has had a compound annual growth rate (CAGR) of -24.32% in market capitalization. This means its market cap has shrunk at an average rate of -24.32% per year.

Nautilus Biotechnology (NAUT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.